Trial Profile
Outcomes of Planned Conversion From Tacrolimus to Sirolimus-based Immunosuppressive Regimen in de Novo Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Mycophenolate sodium; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 22 May 2013 Final analysis presented at the American Transplant Congress - 13th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
- 06 Mar 2013 New trial record